Diseases, Conditions, Syndromes

Racial disparities exist in end-of-life care for US dialysis patients

At the end of life, black patients with kidney failure receiving chronic dialysis are less likely to be referred to hospice and to discontinue dialysis compared with white patients, according to a study appearing in an upcoming ...

Diseases, Conditions, Syndromes

Hispanics live longest, whites shortest among dialysis patients

Among kidney failure patients on dialysis, Hispanics tend to live the longest and Whites the shortest, with Blacks' survival time in between these two, according to a study appearing in an upcoming issue of the Clinical Journal ...

Cardiology

Irregular heart beat elevates risk of kidney failure

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease – the complete failure of the kidneys – placing them ...

Diseases, Conditions, Syndromes

Serious acute kidney injury: More common than ever

Acute kidney injury (AKI), an abrupt or rapid decline in kidney function, is a serious and increasingly prevalent condition that can occur after major infections, major surgery, or exposure to certain medications. The incidence ...

Diseases, Conditions, Syndromes

Chronic kidney disease alters intestinal microbial flora, study finds

(Medical Xpress)—Chronic kidney disease changes the composition of intestinal bacterial microbes that normally play a crucial role in staving off disease-causing pathogens and maintaining micronutrient balance, according ...

Diseases, Conditions, Syndromes

Role of screening, monitoring in early kidney disease unclear

(HealthDay) -- At least one in 10 U.S. adults is estimated to have chronic kidney disease, but whether screening and monitoring people in the earlier stages of the disease provides a benefit just isn't clear, a new review ...

Medical research

Study targets key molecule to reverse kidney damage in mice

In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess Medical Center (BIDMC) and their colleagues have identified a key molecular player and shown how ...

page 5 from 6